Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Oat Beta Glucan,Avenanthramides
Therapeutic Area : Dermatology
Study Phase : Approved
Recipient : Ceapro
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the agreement, Symrise is guaranteed to purchase minimum annual volumes of Ceapro’s high value active ingredients. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions.
Brand Name : Juvente
Molecule Type : Small molecule
Upfront Cash : Undisclosed
March 10, 2022
Lead Product(s) : Oat Beta Glucan,Avenanthramides
Therapeutic Area : Dermatology
Highest Development Status : Approved
Recipient : Ceapro
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?